Related Experiment Video
Updated: Oct 15, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy
A Hoyer1, E M Rehbinder2,3, M Färdig1,4
1Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Insights
Filaggrin (FLG) mutations are linked to eczema and atopic dermatitis (AD) in infants. While not initially impacting skin barrier function or dryness, FLG mutations increase eczema risk and localized dry skin by 3-6 months.
Area of Science:
- Dermatology
- Genetics
- Pediatrics
Background:
- Loss-of-function mutations in the filaggrin (FLG) gene are associated with increased atopic dermatitis (AD) risk.
- The precise role of FLG mutations in infant skin barrier function, dry skin, and eczema remains unclear.
Purpose of the Study:
- To investigate the impact of FLG mutations on skin barrier function, dry skin, eczema, and AD in infants at 3 months and throughout the first year of life.
Main Methods:
- Analysis of FLG mutations in 1836 infants from the Scandinavian PreventADALL study.
- Assessment of transepidermal water loss (TEWL), dry skin, eczema, and AD at 3, 6, and 12 months of age.
Main Results:
- FLG mutations were found in 9% of infants. At 3 months, FLG mutations were associated with eczema (OR 2.89) but not impaired skin barrier function or general dry skin.
- By 6 months, mutation carriers exhibited significantly higher TEWL. Increased risk of dry skin on the trunk and extensor limbs was observed at 3 and 6 months in mutation carriers.
- FLG mutations were significantly associated with the development of eczema and AD during infancy.
Conclusions:
- FLG mutations do not initially impair skin barrier function or cause generalized dry skin in 3-month-old infants.
- However, FLG mutations increase the risk of eczema and localized dry skin on the trunk and extensor limbs by 3-6 months of age.
- The study confirms the association of FLG mutations with eczema and atopic dermatitis throughout infancy.
Background:
Loss-of-function mutations in the skin barrier gene filaggrin (FLG) increase the risk of atopic dermatitis (AD), but their role in skin barrier function, dry skin and eczema in infancy is unclear.
Objectives:
To determine the role of FLG mutations in impaired skin barrier function, dry skin, eczema and AD at 3 months of age and throughout infancy.
Methods:
FLG mutations were analysed in 1836 infants in the Scandinavian population-based PreventADALL study. Transepidermal water loss (TEWL), dry skin, eczema and AD were assessed at 3, 6 and 12 months of age.
Results:
FLG mutations were observed in 166 (9%) infants. At 3 months, carrying FLG mutations was not associated with impaired skin barrier function (TEWL > 11·3 g m-2 h-1 ) or dry skin, but was associated with eczema [odds ratio (OR) 2·89, 95% confidence interval (CI) 1·95-4·28; P < 0·001]. At 6 months, mutation carriers had significantly higher TEWL than nonmutation carriers [mean 9·68 (95% CI 8·69-10·68) vs. 8·24 (95% CI 7·97-8·15), P < 0·01], and at 3 and 6 months mutation carriers had an increased risk of dry skin on the trunk (OR 1·87, 95% CI 1·25-2·80; P = 0·002 and OR 2·44, 95% CI 1·51-3·95; P < 0·001) or extensor limb surfaces (OR 1·52, 95% CI 1·04-2·22; P = 0·028 and OR 1·74, 95% CI 1·17-2·57; P = 0·005). FLG mutations were associated with eczema and AD in infancy.
Conclusions:
FLG mutations were not associated with impaired skin barrier function or dry skin in general at 3 months of age, but increased the risk for eczema, and for dry skin on the trunk and extensor limb surfaces at 3 and 6 months.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Inborn Errors of Metabolism
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Desmosomes
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...

